Rheumatoid factor: Difference between revisions
From IDWiki
No edit summary |
m (→) |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
== Background == |
== Background == |
||
* IgM |
* General class of IgM antibodies to the Fc region of IgG |
||
*Most asymptomatic people with positive RF do ''not'' progress to [[rheumatoid arthritis]] |
*Most asymptomatic people with positive RF do ''not'' progress to [[rheumatoid arthritis]] |
||
*Neither specific nor sensitive for [[RA]] |
*Neither specific nor sensitive for [[RA]] |
||
Line 9: | Line 9: | ||
* Rheumatic disorders |
* Rheumatic disorders |
||
** [[Rheumatoid arthritis]] (26-90%) |
** [[Rheumatoid arthritis]] (26-90%) |
||
** |
**[[Systemic lupus erythematosus]] (15-35%), [[Sjögren syndrome]] (75-95%), and [[mixed connective tissue disorder]] (50-60%) |
||
** Type II and III [[cryoglobulinemia]] (40-100%) |
** Type II and III [[cryoglobulinemia]] (40-100%) |
||
** [[Polymyositis]] and [[dermatomyositis]] (5-10%) |
** [[Polymyositis]] and [[dermatomyositis]] (5-10%) |
Latest revision as of 10:39, 27 March 2022
Background
- General class of IgM antibodies to the Fc region of IgG
- Most asymptomatic people with positive RF do not progress to rheumatoid arthritis
- Neither specific nor sensitive for RA
Differential Diagnosis
- Rheumatic disorders
- Rheumatoid arthritis (26-90%)
- Systemic lupus erythematosus (15-35%), Sjögren syndrome (75-95%), and mixed connective tissue disorder (50-60%)
- Type II and III cryoglobulinemia (40-100%)
- Polymyositis and dermatomyositis (5-10%)
- Chronic infections
- Bacterial endocarditis (25-50%)
- Hepatitis B and hepatitis C (20-75%)
- Other viruses, such as HIV, Epstein-Barr virus, and CMV
- Some parasites, including malaria, schistosomiasis, and toxoplasmosis
- Inflammatory disorders
- Cirrhosis (25%)
- Primary biliary cirrhosis (45-70%)
- Idiopathic pulmonary fibrosis (10-50%)
- Sarcoidosis (3-33%)
- Silicosis and asbestosis (30-50%)
- Malignancies
- B-cell disorders (5-25%)
- Normal aging
- ≥65 years of age (5-25%)
Further Reading
- Rheumatoid Factors: Clinical Applications. Dis Markers. 2013;35(6):727–734. doi: 10.1155/2013/726598